US Aid Cuts Cripple South Africa‘s Vital Health Research, Threatening Global Progress

Johannesburg, South Africa – Decades of groundbreaking health research in South Africa, particularly in the fight against HIV and tuberculosis, are facing an existential crisis following significant cuts to U.S.aid. The reduction in funding, which has already led to widespread layoffs and the emptying of laboratories, threatens to unravel progress made in tackling some of the world’s most pressing health challenges and jeopardizes future global health initiatives.Dr. Glenda Grey, president of the South African Medical Research Council, voiced grave concerns about the impact of these cuts. “South Africa has been a powerhouse for research, delivering better, faster, and cheaper than anywhere else in the world,” Gray stated. “Without South Africa as part of these programs, the world, from my personal perspective, is much poorer.” She highlighted South Africa’s critical role during the COVID-19 pandemic, where its scientists were instrumental in testing the Johnson & Johnson and Novavax vaccines and identifying a key variant through genomic surveillance.

Labs Empty and Thousands Are Laid Off

at the University of the Witwatersrand, a team of researchers has been at the forefront of developing HIV vaccines. Inside their laboratory, technician Nozipho Mlotshwa, a young scientist supporting her family and funding her own studies in a country with a staggering 46% youth unemployment rate, faces an uncertain future. Her position is grant-funded, and the U.S. cuts have cast a long shadow of devastation. “It’s very sad and devastating, honestly,” Mlotshwa shared, lamenting the potential loss of collaboration with scientists across the continent.

Professor Abdullah Ely, who leads the research team, confirmed that their promising work, which showed vaccines eliciting a strong immune response, has been forced to a standstill. The BRILLIANT program, a key initiative, is desperately seeking choice funding to salvage the project, with the purchase of essential equipment halted. South Africa’s health department reports that approximately 100 researchers involved in HIV-related programs have been laid off, and funding for postdoctoral students is also at risk.

The South African government estimates that universities and science councils could lose around $107 million in U.S. research funding over the next five years. These cuts extend beyond HIV research to encompass tuberculosis,another disease that disproportionately affects the nation.

Less Money, and Less Data on What’s Affected

The South African government has acknowledged the immense difficulty in securing replacement funding for the significant U.S. support. the repercussions are immediate and severe: an anticipated rise in HIV infections and increased challenges in accessing medication. The government has confirmed that at least 8,000 health workers in South Africa’s HIV program have already been laid off. Crucially, the data collectors who meticulously tracked patients and their care, along with HIV counselors vital for reaching vulnerable populations in rural areas, are also gone.

In response to the crisis, Universities South Africa, an umbrella association, has formally requested over $110 million from the national treasury to sustain projects at several major academic institutions.

During a visit to South Africa in June, UNAIDS Executive Director Winnie Byanyima underscored the gravity of the situation, recognizing the lives at stake as research and healthcare infrastructure falter across South Africa and the broader African continent. Byanyima noted that other nations heavily reliant on U.S. funding, including Zambia, Nigeria, Burundi, and Ivory Coast, are beginning to allocate their own resources.However, she cautioned, “But let’s be clear, what they are putting down will not be funding likewise that the American resources were funding.”

Magome writes for the Associated Press. Associated Press writer Michelle Gumede in Johannesburg contributed to this report.